Key result
Cardiopulmonary exercise testing is a core assessment for evaluating prognosis and disease severity in patients with heart failure.
Answers are grounded in this paper and cite their sources.
Cardiopulmonary exercise testing (CPX) provides high-value prognostic and disease severity information, supporting its use as a core assessment in the heart failure population.
Despite advances in the treatment of heart failure (HF), which have resulted in improved survival, overall prognosis continues to be poor. Given the high short-term mortality rate, it remains important to utilize assessment techniques with established prognostic value in this patient population. Ideally, a given assessment should also be able to accurately reflect disease severity, a heterogeneous phenomenon in patients with HF, and accurately reflect the magnitude of physiologic/clinical improvement following the implementation or titration of an intervention. Cardiopulmonary exercise testing (CPX) satisfies all of the aforementioned desirable assessment attributes. Peak oxygen consumption and the minute ventilation/carbon dioxide production slope are key CPX variables in assessing prognosis and gauging disease severity. Given the high value of information obtained from this procedure, CPX should be considered a core assessment in the HF population. The current review will concisely define key CPX variables and summarize their clinical applications in patients with HF.
No takes yet. Share an insight, caveat, or question.
Arena et al. (2011) conducted a review in Heart failure. Cardiopulmonary exercise testing (CPX) was evaluated. Cardiopulmonary exercise testing is a core assessment for evaluating prognosis and disease severity in patients with heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: